Cytokinetics News

Cytokinetics (CYTK) Opens Second Cohort for ATOMIC-AHF Phase IIb

Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart Failure

Cytokinetics to Hold Annual Meeting of Stockholders

SOUTH SAN FRANCISCO, CA-- - Cytokinetics, Incorporated announced today that its Annual Meeting of Stockholders will be held on Tuesday, May 22, 2012 at 10:00 AM Pacific Time at the Embassy Suites Hotel, ...

Cytokinetics Announces Company Participation and Support of ALS Fundraising Activities in Connection With ALS Awareness Month

SOUTH SAN FRANCISCO, CA-- - Cytokinetics, Incorporated announced today that, in connection with Amyotrophic Lateral Sclerosis Awareness Month, the company has committed to several educational and support ...

CYTOKINETICS INC Files SEC form 10-Q, Quarterly Report

New Star Analyst Rankings for Cytokinetics, Incorporated

Cytokinetics, Inc. (CYTK) Tops Q1 EPS by 1c

CYTOKINETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statement

Cytokinetics, Incorporated Reports First Quarter 2012 Financial Results

SOUTH SAN FRANCISCO, CA-- - Cytokinetics, Incorporated reported total research and development revenues of $1.8 million for the first quarter of 2012. The net loss for the first quarter was $9.9 million, ...

Cytokinetics Announces Presentation of Preclinical Data Regarding CK-2017357 at the 2012 Experimental Biology Annual Conference

SOUTH SAN FRANCISCO, CA-- - Cytokinetics, Incorporated announced today that preclinical data regarding CK-2017357 were presented in a poster presentation at the 2012 Experimental Biology Annual Conference ...

Q1 2012 Cytokinetics, Inc. Earnings Release - 4:00 pm ET

CYTOKINETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits

Cytokinetics Announces Encouraging Results From Two Phase II Clinical Trials Evaluating CK-2017357 in Patients With Amyotrophic Lateral Sclerosis

Cytokinetics to Announce First Quarter Results on April 26, 2012

SOUTH SAN FRANCISCO, CA-- - Cytokinetics, Incorporated announced today that it is scheduled to report first quarter results on Thursday, April 26, 2012 at 4:00 PM Eastern Time. Following the announcement, ...

Cytokinetics ALS drug wins 'fast track' designation